HPV — Study With Candida Antigen for Treatment of Warts
Citation(s)
Baker GE, Tyring SK Therapeutic approaches to papillomavirus infections. Dermatol Clin. 1997 Apr;15(2):331-40. Review.
Brunk D Injection of Candida antigen works on warts. Skin and Allergy News. 1999; 30(12):5.
Horn TD, Johnson SM, Helm RM, Roberson PK Intralesional immunotherapy of warts with mumps, Candida, and Trichophyton skin test antigens: a single-blinded, randomized, and controlled trial. Arch Dermatol. 2005 May;141(5):589-94.
Johnson SM, Brodell RT Treating warts: a review of therapeutic options. Consultant 1999;39(1):253-266.
Johnson SM, Roberson PK, Horn TD Intralesional injection of mumps or Candida skin test antigens: a novel immunotherapy for warts. Arch Dermatol. 2001 Apr;137(4):451-5.
Majewski S, Jablonska S Human papillomavirus-associated tumors of the skin and mucosa. J Am Acad Dermatol. 1997 May;36(5 Pt 1):659-85; quiz 686-8. Review.
MASSING AM, EPSTEIN WL Natural history of warts. A two-year study. Arch Dermatol. 1963 Mar;87:306-10.
Miller DM, Brodell RT Human papillomavirus infection: treatment options for warts. Am Fam Physician. 1996 Jan;53(1):135-43, 148-50. Review.
Pfister H Human papillomaviruses and skin cancer. Semin Cancer Biol. 1992 Oct;3(5):263-71. Review.
Quan MB, Moy RL The role of human papillomavirus in carcinoma. J Am Acad Dermatol. 1991 Oct;25(4):698-705. Review.
A Phase 1 Study to Evaluate the Immunologic Mechanisms Underlying Wart Resolution After Intralesional Immunotherapy With Candida Antigen
Interventional studies are often prospective and are specifically tailored to evaluate direct impacts of treatment or preventive measures on disease.
Observational studies are often retrospective and are used to assess potential causation in exposure-outcome relationships and therefore influence preventive methods.
Expanded access is a means by which manufacturers make investigational new drugs available, under certain circumstances, to treat a patient(s) with a serious disease or condition who cannot participate in a controlled clinical trial.
Clinical trials are conducted in a series of steps, called phases - each phase is designed to answer a separate research question.
Phase 1: Researchers test a new drug or treatment in a small group of people for the first time to evaluate its safety, determine a safe dosage range, and identify side effects.
Phase 2: The drug or treatment is given to a larger group of people to see if it is effective and to further evaluate its safety.
Phase 3: The drug or treatment is given to large groups of people to confirm its effectiveness, monitor side effects, compare it to commonly used treatments, and collect information that will allow the drug or treatment to be used safely.
Phase 4: Studies are done after the drug or treatment has been marketed to gather information on the drug's effect in various populations and any side effects associated with long-term use.
